Point72 Asset Management L.P. Decreases Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Point72 Asset Management L.P. lowered its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 35.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,474,220 shares of the company’s stock after selling 808,590 shares during the quarter. Point72 Asset Management L.P. owned 1.59% of Acadia Healthcare worth $58,453,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. SG Americas Securities LLC raised its holdings in Acadia Healthcare by 713.3% in the fourth quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock valued at $4,396,000 after acquiring an additional 97,235 shares in the last quarter. Beach Point Capital Management LP purchased a new position in Acadia Healthcare in the fourth quarter worth approximately $14,097,000. Sterling Capital Management LLC grew its holdings in Acadia Healthcare by 59.1% during the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company’s stock worth $216,000 after acquiring an additional 2,026 shares in the last quarter. Finally, Stephens Investment Management Group LLC increased its position in shares of Acadia Healthcare by 24.9% in the 4th quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company’s stock valued at $58,490,000 after purchasing an additional 294,210 shares during the last quarter.

Analysts Set New Price Targets

ACHC has been the topic of a number of analyst reports. Royal Bank of Canada cut their price target on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Mizuho lowered their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a report on Wednesday. Bank of America cut their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. KeyCorp dropped their price objective on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a report on Wednesday. Finally, Guggenheim assumed coverage on Acadia Healthcare in a report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 target price for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $47.94.

Acadia Healthcare Stock Down 0.3%

ACHC opened at $25.64 on Friday. The business has a 50 day moving average price of $26.25 and a two-hundred day moving average price of $35.83. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The company has a market cap of $2.36 billion, a PE ratio of 8.41, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s revenue for the quarter was up .3% on a year-over-year basis. During the same period last year, the company earned $0.84 earnings per share. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.